Evolus (EOLS) Capital Expenditures (2019 - 2026)
Evolus (EOLS) posted Capital Expenditures of $50,000 for Q2 2026, down 92.7% from $688,000 a year earlier and down 88.0% from the prior quarter.
Evolus (EOLS) Capital Expenditures (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Evolus was $2.9 million, up 64.9% year-over-year; for FY2025, it came in at $3.44 million, up 133.8% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of 33.4% (FY2020 to FY2025).
- In prior years, Evolus' Capital Expenditures was $1.47 million in FY2024 (+211.2%), $473,000 in FY2023 (-70.8%), $1.62 million in FY2022 (+311.7%) and $393,000 in FY2021 (-51.8%).
- The Q2 2026 figure stands as the lowest quarterly Capital Expenditures since Q3 2023.
- On a year-over-year basis, Capital Expenditures increased in seven of the last eight quarters, with growth averaging 192.7%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q3 2024, with growth of 979.3%; the weakest was Q2 2023, with a decline of 96.5%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $415,000 (Q1 2026), $1.48 million (Q4 2025) and $955,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Evolus | 527.45 Mn | 335.14 Mn | 57.18 Mn | 50,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50,000.00 |
| Mar 31, 2026 | 415,000.00 |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | 955,000.00 |
| Jun 30, 2025 | 688,000.00 |
| Mar 31, 2025 | 319,000.00 |
| Dec 31, 2024 | 438,000.00 |
| Sep 30, 2024 | 313,000.00 |
| Jun 30, 2024 | 465,000.00 |
| Mar 31, 2024 | 256,000.00 |
| Dec 31, 2023 | 209,000.00 |
| Sep 30, 2023 | 29,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Mar 31, 2023 | 227,000.00 |
| Dec 31, 2022 | 866,000.00 |
| Sep 30, 2022 | 509,000.00 |
| Jun 30, 2022 | 231,000.00 |
| Mar 31, 2022 | 12,000.00 |
| Dec 31, 2021 | 393,000.00 |
| Dec 31, 2020 | 17,000.00 |
Evolus Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EOLS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();